WISDOM: Risk-Based Breast Cancer Screening
/ Martin Eklund
Chemotherapy Use After the RxPONDER Trial
/ Jason Jincong Freeman
Cost-Effectiveness of Breast Cancer Screening in Europe
/ Zacharoula Sidiropoulou
Beyond Symptoms: What Matters Most to Women Living with Metastatic Breast Cancer?
/ Lærke K. Tolstrup / Marianne Vogsen / Malene Grubbe Hildebrandt / Regina W. Sørensen / Karin B. Dieperink
Instructional Videos Optimise Patient Compliance with Respiratory-Gated Breast Cancer Radiotherapy
/ Kristine Wiborg Høgsbjerg
ESMO Breast 2026: Optimizing Immunotherapy in Early TNBC
/ Giampaolo Bianchini
TP53 Mutations as a Predictive Biomarker in High-Risk Breast Cancer
/ Mari Eskild Rasmussen
AI-Based Extraction of Retrospective Pathology Data for Breast Cancer Research
/ Agnar Martin Bjørnstad











